Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $19.3500 (8.95%) ($16.7600 - $19.4600) on Fri. Mar. 13, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4% (three month average) | RSI | 40 | Latest Price | $19.3500(8.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -4.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -5.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(59%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -2% in a week (0% probabilities). VIXM(-31%) VXX(-16%) UUP(-7%) TLT(-2%) TBT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2% (StdDev 4%) | Hourly BBV | 0 () | Intraday Trend | -0.4% | | | |
|
1 - 5 Day Possible Target | $1.22(-93.7%) | Resistance Level | $22.88 | 5 Day Moving Average | $20.07(-3.59%) | 10 Day Moving Average | $21.62(-10.5%) | 20 Day Moving Average | $22.88(-15.43%) | To recent high | -41% | To recent low | 9% | Market Cap | $1.202b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |